share_log

丽珠集团:向控股子公司增资10亿元

Livzon Pharmaceutical Group Inc.: Increase capital by 1 billion yuan to the subsidiary.

Breakings ·  Mar 26 11:37

Livzon Pharmaceutical Group Inc. announced that the company plans to use its own funds of 1 billion yuan to increase capital for its controlling subsidiary, Zhuhai Livzon Biomedical Technology Co., Ltd. It will subscribe to 0.206 billion newly issued ordinary shares of Livzon Biomedical, increasing its shareholding ratio from 60.23% to 66.54%. This capital increase aims to meet the funding needs of Livzon Biomedical's R&D projects and daily operational activities, optimize the capital structure, and aligns with the company's Global Strategy. The trade requires approval from the shareholders' meeting and the Livzon Biomedical shareholders' conference.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Comment Comment · Views 210

Recommended

Write a comment

Statement

This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.